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ABSTRACT Salmonella enterica serovar Typhimurium genome encodes 13 fimbrial
operons. Most of the fimbriae encoded by these operons are not produced under
laboratory conditions but are likely to be synthesized in vivo. We used an in vivo ex-
pression technology (IVET) strategy to identify four fimbrial operons, agf, saf, sti, and
stc that are expressed in the spleen. When any three of these operons were deleted,
the strain retained wild-type virulence. However, when all four operons were de-
leted, the resulting strain was completely attenuated, indicating that these four fim-
briae play functionally redundant roles critical for virulence. In mice, oral doses of as
low as 1  105 CFU of the strain with four fimbrial operons deleted provided 100%
protection against challenge with 1  109 CFU of wild-type S. Typhimurium. We also
examined the possible effect of these fimbriae on the ability of a Salmonella vaccine
strain to deliver a guest antigen. We modified one of our established attenuated
vaccine strains, 9088, to delete three fimbrial operons while the fourth operon was
constitutively expressed. Each derivative was modified to express the Streptococcus
pneumoniae antigen PspA. Strains that constitutively expressed saf or stc elicited a
strong Th1 response with significantly greater levels of anti-PspA serum IgG and
greater protective efficacy than strains carrying saf or stc deletions. The isogenic
strain in which all four operons were deleted generated the lowest anti-PspA levels
and did not protect against challenge with virulent S. pneumoniae. Our results indi-
cate that these fimbriae play important roles, as yet not understood, in Salmonella
virulence and immunogenicity.
IMPORTANCE Salmonella enterica is the leading cause of bacterial food-borne in-
fection in the United States. S. Typhimurium is capable of producing up to 13 dis-
tinct surface structures called fimbriae that presumably mediate its adherence to
surfaces. The roles of most of these fimbriae in disease are unknown. Identifying
fimbriae produced during infection will provide important insights into how these
bacterial structures contribute to disease and potentially induce protective immunity
to Salmonella infection. We identified four fimbriae that are produced during infec-
tion. Deletion of all four of these fimbriae results in a significant reduction in viru-
lence. We explored ways in which the expression of these fimbriae may be exploited
for use in recombinant Salmonella vaccine strains and found that production of Saf
and Stc fimbriae are important for generating a strong immune response against a
vectored antigen. This work provides new insight into the role of fimbriae in disease
and their potential for improving the efficacy of Salmonella-based vaccines.
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Bacterial pathogens produce adhesins, often associated with fimbrial structures onthe cell surface, to facilitate their initial interactions with host tissues (1). The
chromosome of Salmonella enterica serovar Typhimurium contains 13 fimbrial operons,
agf (csg), bcf, fim, lpf, pef, saf, stb, stc, std, stf, sth, sti, and stj (2–4). While the functions
of a few of these fimbriae, including type 1 fimbriae (Fim), have been characterized (1,
5), the functions of most fimbriae are unknown. This is due, in part, to the fact that only
type 1 and Agf fimbriae are produced under laboratory growth conditions (6). Type 1
fimbriae are produced when cells are grown at 37°C, and Agf fimbriae are produced
when cells are grown at 26°C (7). While it is possible that some of these other fimbriae
may be required for life outside a host (8), it is likely that many play an as yet
undiscovered role in host interactions.
The agf operon encodes thin aggregative fimbriae (9) in Salmonella, and these
fimbriae were later found to be similar to the fibronectin-binding surface structure
known as curli (10) originally described in Escherichia coli (11). Thin aggregative
fimbriae (hereafter Agf fimbriae) and curli are not produced in vitro at 37°C (11).
Production of Agf fimbriae is typically induced in laboratory settings by growing cells
at 26°C. Pef fimbriae mediate adherence to the murine small intestine and are required
for fluid accumulation in infant mice. Expression of pef genes is regulated by DNA
methylation (12). Stf fimbriae share homology with MR/P fimbriae of Proteus mirabilis
and E. coli Pap fimbriae (13), and expression of stfA is induced during infection of bovine
ileal loops (14). Long polar fimbriae (Lpf) are important for colonization of Peyer’s
patches in mice by mediating adherence to M cells (5). Lpf also plays a role in the early
stages of biofilm formation on host epithelial cells (15) and is involved in intestinal
persistence (16). Lpf synthesis is regulated by an on-off switch mechanism (phase
variation) to avoid host immune responses (17).
Some S. enterica fimbriae have been shown to serve functions beyond those
required for interactions at the intestinal mucosal surface. For example, the Agf fimbriae
are required for biofilm formation in the gallbladder (18, 19). In addition, the Stg
fimbriae of S. enterica serovar Typhi, required for adherence to epithelial cells, also
serves to inhibit phagocytosis (20). In S. Typhimurium, most fimbriae are produced in
vivo, since mice immunized with S. Typhimurium produce antibodies against fimbrial
subunits AgfA, BcfA, FimA, LpfA, PefA, StbA, StcA, StdA, StfA, SthA, and StiA (6). Thus,
it is likely that some of these uncharacterized fimbriae may be synthesized in extraint-
estinal tissues.
To investigate potential roles for S. Typhimurium fimbriae in the host, we utilized an
in vivo expression technology (IVET) strategy (21). We identified four fimbrial operons
that are actively expressed in the spleen, only one of which, agf, is synthesized during
in vitro growth (at 26°C). We characterized the impact of deletion and constitutive
expression of all four fimbriae on virulence and immunogenicity.
RESULTS
Identification of fimbrial operons expressed in the spleen by IVET. We con-
structed 12 S. Typhimurium strains, each harboring chromosomal transcriptional fu-
sions of fimbrial promoter regions with aph lacZ reporter genes (Fig. 1). The stj operon
is incomplete due to the apparent absence of any identifiable fimbrial subunit genes,
so it was not included in our study (2). However, it is likely that this operon encodes a
nonfimbrial or fibrillar structure (4). A mixture of all 12 fusion strains were orally
administered to BALB/c mice. After infection, mice were treated orally and intraperito-
neally with three doses of kanamycin to select for S. Typhimurium clones expressing the
aph reporter gene in vivo. The experiment was performed twice, and 96 clones were
obtained from pooled spleen samples in each experiment. Clones were identified by
PCR using specific primers (see Table S2 in the supplemental material). In both
experiments, we recovered the same four S. Typhimurium strains, strains 9451, 9453,
9456, and 9461, which contain aph lacZ reporter genes fused to the promoter
regions of stiABCH, safABCD, agfBAC, and stcABCD operons, respectively (Table 1). Each
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of these strains was sensitive to kanamycin when grown at 37°C on LB agar plates,
indicating that these four fimbrial operons are expressed in the mouse host.
Virulence and immunogenicity of S. Typhimurium fimbrial mutants in BALB/c
mice. Because these fimbrial promoters are active in the spleen, we hypothesized
that the fimbriae may be important for virulence. Therefore, we constructed strains
harboring single and multiple deletions of the four fimbrial operons, ΔstiABCH1225,
ΔsafABCD31, Δ(agfC-agfG)-999, and ΔstcABCD36. BALB/c mice were orally administered
graded doses of bacteria and monitored for 4 weeks. All single deletion mutants
FIG 1 Construction of pSG3-based aph lacZ fusions in S. Typhimurium fimbrial operons. Promoters were isolated as PCR products ranging
from 271 to 391 bp and cloned into plasmid pSG3 to construct chromosomal fusions of each fimbrial operon promoter to aph. The
resulting promoter fusions are illustrated. Strains are resistant to kanamycin only when the corresponding fimbrial promoter is active.
Fimbria Production in Live Salmonella Vaccines ®
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retained wild-type virulence (data not shown). Strains with any three of the four fimbrial
operons deleted were also virulent (Table 2). In contrast, two independently con-
structed quadruple deletion mutants, 11484 and 11599, were fully attenuated, with
no deaths or disease symptoms occurring at the highest dose tested (50% lethal dose
[LD50]  ~1  109 to 2  109 CFU).
We evaluated the immunogenicity of one of the strains, 11484, by determining its
ability to confer protection against challenge with the virulent S. Typhimurium UK-1
strain 3761. The mice used in the virulence assay (above), which received graded
doses of strain 11484 were challenged 4 weeks after immunization with S. Typhimu-
rium 3761 (Table 3). A control group was given sterile buffer. Protection was achieved
at all doses, and all mice that were immunized with at least 1.4  105 CFU of 11484
survived challenge with the virulent S. Typhimurium strain (Table 3). Even mice inoc-
ulated with a single dose of only 8.4 102 CFU were partially protected, indicating that
this avirulent S. Typhimurium fimbrial quadruple mutant is highly immunogenic.
Colonization by S. Typhimurium fimbrial quadruple mutants. To evaluate the
impact of the quadruple deletion on colonization, mice were orally inoculated with either
strain 11484 or strain 11599. Peyer’s patches, spleens, and livers were harvested 5 days
later, and the bacteria in each tissue were enumerated. Both quadruple mutants colonized
all tested organs as well as wild-type 3761 strain did (data not shown). To look more
closely at spleen and liver colonization, we performed a competition assay. We chose to
inoculate by the intraperitoneal route to eliminate any differences between strains that
might be due to passage through the gastrointestinal tract. Thus, mice were inoculated
parenterally with a mixture of S. Typhimurium wild-type 3761 and either 11484 or
11599. Each strain was marked with a stable low-copy-number chloramphenicol-resistant
plasmid (pHSG576) or kanamycin-resistant plasmid (pWSK129). Groups of mice were eu-
TABLE 2 Virulence of S. Typhimurium fimbrial mutants in BALB/c micea
Strain Relevant genotype
Oral LD50 (CFU)
Expt 1 Expt 2
3761 Wild-type 3.5  102 NTb
11467 Δ(agfC-agfG)-999 ΔsafABCD31 ΔstcABCD36 4.2  103 5.1  102
11483 ΔsafABCD31 ΔstiABCH1225 Δ(agfC-agfG)-999 1.0  103 4.1  102
11505 ΔsafABCD31 ΔstiABCH1225 ΔstcABCD36 5.6  102 4.0  102
11507 Δ(agfC-agfG)-999 ΔstiABCH1225 ΔstcABCD36 1.8  102 1.2  103
11484 ΔsafABCD31 ΔstiABCH1225 Δ(agfC-agfG)-999 ΔstcABCD36 1.2  109 2.0  109
11599 ΔsafABCD31 ΔstiABCH1225 ΔstcABCD36 Δ(agfC-agfG)-999 1.6  109 1.3  109
aBALB/c mice were orally administered graded doses of the indicated strains and monitored for 4 weeks.
bNT, not tested.
TABLE 1 Identification of S. Typhimurium fimbrial operons expressed in spleen using in
vivo expression technology
Strain
Relevant reporter
fusion for IVET
No. of PCR-positive clones (%)
detected in spleen after
kanamycin treatment (n  96)
Expt 1 Expt 2
9450 Pbcf::pl-aph pl-lacZ 0 0
9451 Psti::pl-aph pl-lacZ 42 (44) 10 (10)
9452 Pstf::pl-aph pl-lacZ 0 0
9453 Psaf::pl-aph pl-lacZ 19 (20) 59 (61)
9454 Pstb::pl-aph pl-lacZ 0 0
9455 Pfim::pl-aph pl-lacZ 0 0
9456 Pagf::pl-aph pl-lacZ 26 (27) 7 (7)
9457 Pstd::pl-aph pl-lacZ 0 0
9458 Plpf::pl-aph pl-lacZ 0 0
9459 Psth::pl-aph pl-lacZ 0 0
9460 Ppef::pl-aph pl-lacZ 0 0
9461 Pstc::pl-aph pl-lacZ 5 (5) 17 (18)
Unidentified 4 3
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thanized on days 1 and 3 postinfection. Samples of the spleens and livers were plated for
enumeration of Salmonella. The total numbers of Salmonella recovered from each organ
were consistent from mouse to mouse, between 104 and 106 CFU per g of tissue (data not
shown). The ratio of the two strains in each organ was determined and compared to the
input ratio to determine the competitive index (CI). On day 1 postinfection, there were no
differences in spleen colonization between wild-type and mutant strains (Fig. 2B), while
strain 11484, but not 11599, was outcompeted by the wild-type strain in the liver
(Fig. 2A) (P  0.01). By day 3, the wild type had outcompeted both quadruple mutants in
both the spleen and liver (P  0.05), indicating an important role for saf, sti, stc, and agf in
colonization of the spleen and liver in mice. In preliminary competition experiments
comparing single deletion mutants and the wild type, no significant differences were
observed between strains (data not shown), indicating that no single fimbria is responsible
for this phenotype.
Recombinant attenuated S. Typhimurium vaccine (RASV) strains producing
fimbriae (Saf, Sti, Stc, and Agf) in a constitutive manner. Our results showing
that the saf, sti, stc and agf fimbrial operons are expressed in vivo led us to speculate
as to whether these fimbriae could be exploited to enhance the immunogenicity and
protective efficacy of Salmonella vaccine strains. For this work, we constructed deriv-
atives of attenuated S. Typhimurium strain 9088 [ΔPfur33::TT araC PBAD fur Δpmi-2426
Δ(gmd-fcl)-26 ΔasdA33] (22) in which three fimbrial operons were deleted and the
fourth was expressed from the constitutive PmurA promoter (23). Consequently, the
resulting strains, strains 11595, 11850, and 11851, have a genetic background that
includes attenuating mutations, deletions in three fimbrial operons, and one deletion-
insertion mutation (Table 4). The agf genes are expressed from two divergent operons,
agfDEFG and agfBAC, necessitating a different strategy. In this case, we introduced the
previously described agfD812 mutation (24) to drive constitutive expression of the agf
operon. Strain 12038 constitutively produced Agf fimbriae as indicated by the red, dry,
TABLE 3 Immunogenicity of S. Typhimurium fimbrial quadruple mutant in BALB/c micea
Strain
Dose of
11484 (CFU)
No. of mice alive
after inoculation with
11484/total no.
No. of mice alive after
challenge with 3761/
total no. (% survival)
11484 1.4  109 6/6 6/6 (100)
1.4  107 6/6 6/6 (100)
1.4  105 6/6 6/6 (100)
8.4  102 6/6 4/6 (67)
None (control) 0/3 (0)
aBALB/c mice were immunized orally with the indicated dose of strain 11484 (all mice survived) and
challenged 4 weeks after immunization with ~1  109 CFU of S. Typhimurium wild-type strain (3761).
FIG 2 Effect of saf sti stc agf quadruple deletion on the colonization of mouse liver (A) and spleen (B) by S. Typhimurium.
The competitive indexes were determined from mixed intraperitoneal infection with S. Typhimurium wild-type strain
(3761) and one of two fimbrial quadruple mutants (11484 and 11599). Each symbol represents the value for an organ
from an individual mouse at the indicated day following the infection. The geometric means of the competitive indexes
(mean CI) and the P values from a Student’s t test are given below the graphs.
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and rough (rdar) colony morphology when grown on Congo red plates (7) at 37°C (data
not shown). For a control, we also constructed strain 11606, which harbors deletions
of all four fimbrial operons (agf, saf, sti, and stc).
To study the ability of these strains to elicit protective immune responses against
heterologous antigens in mice, we introduced plasmid pYA4088 (25), carrying the gene
encoding the Streptococcus pneumoniae protein PspA, into each strain. This pneumo-
coccal protein has been extensively studied by our group (26) and others (27, 28) and
shown to elicit protective immunity against virulent S. pneumoniae challenge. For
clarity, we will refer to these strains as 11595(pYA4088) (Sti), 11850(pYA4088)
(Saf), 11851(pYA4088) (Stc), 12038(pYA4088) (Agf), and 11606(pYA4088) (Δ4).
All strains were grown to mid-log phase in LB with appropriate supplements. Western
blot analysis with specific anti-recombinant PspA (anti-rPspA) antibodies showed that
all strains produced similar amounts of PspA (Fig. S1).
Antibody responses in mice immunized with RASV strains constitutively pro-
ducing individual fimbriae (Saf, Sti, Stc, and Agf). BALB/c mice were orally
primed and boosted 6 weeks later with identical doses of ~1  108 CFU of each strain.
A control group was given sterile buffer instead of vaccine. All mice immunized with
RASVs expressing pspA produced anti-rPspA serum IgG1 (Fig. 3A) and IgG2a (Fig. 3B).
No anti-rPspA IgG1 or IgG2a was detected in sera from control mice treated with
TABLE 4 Key bacterial strains and plasmids used in this study
Bacterial strain or
plasmid Relevant characteristic(s)
Reference
or source
E. coli strains
DH5 F 80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17(rK mK)
phoA supE44  thi-1 gyrA96 relA1; used for general cloning
51
BL21(DE3) F ompT hsdSB(rB mB) gal dcm (DE3); used for protein overproduction Novagen
6212 F  80 Δ(lacZYA-argF) endA1 recA1 hsdR17 deoR thi-1 glnV44 gyrA96 relA1 ΔasdA4 52
7213 thi-1 thr-1 leuB6 glnV44 fhuA21 lacY1 recA1 RP4-2-Tc::Mu(pir) ΔasdA4 Δ(zhf-2::Tn10) 46
S. Typhimurium strains
3761 Wild-type UK-1 45
9088 Δpmi-2426 Δ(gmd-fcl)-26 ΔPfur33::TT araC PBAD fur ΔasdA33 22
11467 Δ(agfC-agfG)-999 ΔsafABCD31 ΔstcABCD36 11466
11483 ΔsafABCD31 ΔstiABCH1225 Δ(agfC-agfG)-999 11468
11484 ΔsafABCD31 ΔstiABCH1225 Δ(agfC-agfG)-999 ΔstcABCD36 11483
11505 ΔsafABCD31 ΔstiABCH1225 ΔstcABCD36 11468
11507 Δ(agfC-agfG)-999 ΔstiABCH1225 ΔstcABCD36 11506
11595 Δpmi-2426 Δ(gmd-fcl)-26 ΔPfur33::TT araC PBAD fur ΔasdA33
ΔsafABCD31 Δ(agfC-agfG)-999 ΔstcABCD36 ΔPstiA52::PmurA stiA52
11594
11599 ΔsafABCD31 ΔstiABCH1225 ΔstcABCD36 Δ(agfC-agfG)-999 11505
11606 Δpmi-2426 Δ(gmd-fcl)-26 ΔPfur33::TT araC PBAD fur ΔasdA33
ΔsafABCD31 ΔstiABCH1225 Δ(agfC-agfG)-999 ΔstcABCD36
11597
11850 Δpmi-2426 Δ(gmd-fcl)-26 ΔPfur33::TT araC PBAD fur ΔasdA33
ΔstiABCH1225 Δ(agfC-agfG)-999 ΔstcABCD36 ΔPsafA55::PmurA safA55
11594
11851 Δpmi-2426 Δ(gmd-fcl)-26 ΔPfur33::TT araC PBAD fur ΔasdA33
ΔsafABCD31 ΔstiABCH1225 Δ(agfC-agfG)-999 ΔPstcA53::PmurA stcA53
11597
12038 Δpmi-2426 Δ(gmd-fcl)-26 ΔPfur33::TT araC PBAD fur ΔasdA33
ΔsafABCD31 ΔstiABCH1225 ΔstcABCD36 agfD812
11562
S. pneumoniae strain WU2 Wild-type; virulent; encapsulated type 3 41
Plasmids
pSG3 IVET vector; promoterless aph lacZ mobRP4; R6K ori; Apr Gmr 43
Plasmids used for
production of
recombinant
proteins
pET28b Expression vector; T7 promoter 6xHis lacI; f1 pBR ori; Kmr Novagen
pYA4085 pET30a derivative for overproduction of rPspA 49
pYA4088 pYA3493 derivative for production of rPspA (amino acids 3 to 285)
fused to -lactamase signal sequence
25
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phosphate-buffered saline (PBS). The anti-PspA serum IgG1 titers in all immunized mice
were significantly higher than the titers in mice immunized with strain 11606
(pYA4088) (Δ4) by week 3 (Fig. 3A). The IgG2a subclass concentrations were also greater
than in the 11606(pYA4088) group in all cases except the group immunized with
strain 12038(pYA4088) (Agf) (Fig. 3B). By week 9, IgG2a concentrations were 8- to
14-fold higher in mice immunized with strains 11595(pYA4088) (Sti), 11850
(pYA4088) (Saf), and 11851(pYA4088) (Stc) than in mice immunized with strain
11606(pYA4088) (Δ4) (P 0.0001) (Fig. 3B). The IgG1 subclass concentrations for these
three strains at week 9 were also elevated (2.6- to 4.2-fold) compared to those of
11606(pYA4088) (Δ4) (P  0.0001) (Fig. 3A). Comparing the anti-PspA IgG2a/IgG
isotype ratios showed that immunization with each strain induced a mixed Th1/Th2
response, with a strong Th1 bias (Fig. 3C). At week 9, mice immunized with
11595(pYA4088) (Sti), 11850(pYA4088) (Saf), and 11851(pYA4088) (Stc) showed
the highest IgG2a-to-IgG1 ratios, ranging from 9 to 12 (Fig. 3C). In contrast, mice
immunized with 11606(pYA4088) (Δ4) or 12038(pYA4088) (Agf) showed only two-
to threefold differences in IgG2a-to-IgG1 titers. However, these differences were not
statistically significant (P  0.05).
Protection of mice immunized with RASV strains constitutively producing
individual fimbriae (Saf, Sti, Stc, and Agf) against S. pneumoniae challenge.
Four weeks after the boost, mice were injected intraperitoneally with ~40 times the
LD50 of virulent S. pneumoniae strain WU2. Immunization with strain 11850(pYA4088)
(Saf) and strain 11851(pYA4088) (Stc) provided the highest level of protection
FIG 3 Serum IgG1 and IgG2a responses to PspA in mice immunized with RASV strains expressing fimbriae in a constitutive manner (Saf, Sti,
Stc, and Agf) and producing PspA antigen. The kinetics of serum IgG1 and IgG2a responses to PspA in mice are shown. The data represent
the concentrations of anti-PspA IgG1 (A) and IgG2a (B) in pooled serum samples from eight mice measured in duplicate. Error bars show the
differences between the duplicates (standard deviations). All samples from immunized mice were significantly different from those from the
control group given PBS (P  0.05). Values that are significantly different from the values for the S. Typhimurium 11606(pYA4088) group are
indicated by asterisks as follows: *, P  0.05; **, P  0.01, ****, P  0.0001. (C) Calculated IgG2a/IgG1 ratios based on the data shown in panels
A and B.
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(52.6%) compared to nonimmunized control mice (P  0.001) (Table 5). Strain
11595(pYA4088) (Sti) also provided significant protection against pneumococcal
challenge (31.6%; P  0.05). Vaccination with strain 12038(pYA4088) (Agf) resulted
in 26.3% survival, but this result was not significantly different from that with the
nonimmunized control group. In addition, mice vaccinated with strain 11606
(pYA4088) (Δ4) were not protected (10.5% survival). Two independent protection
experiments were performed. All deaths occurred 4 to 6 days postinfection.
DISCUSSION
Fimbrial genes are widely distributed among bacteria, but only a few fimbriae are
produced under standard laboratory conditions. Most bacterial fimbriae serve to pres-
ent adhesins that assist in the adherence of bacteria to biotic and abiotic surfaces (1)
and are produced in response to the appropriate environmental cues. Of the 13 known
fimbriae in S. Typhimurium, only two, type 1 fimbriae and curli (Agf) are readily
produced when grown in the laboratory. However, in one study, cells were coaxed to
produce Pef, Bcf, Stb, Stc, Std, and Sth fimbriae after static growth in CFA broth at 32°C
and Agf, Pef, Lpf, Stc, Stf, and Sth fimbriae in LB at pH 5.1 at 37°C, although the levels
were low, as fimbriae were detected on 7% of the cells by a highly sensitive flow
cytometry method (14). In the same study, fimbrial expression was further enhanced to
around 10% of cells after growth for 8 h in bovine ileal loops. Type 1 fimbriae were
detected in 20% of the cells under all three growth conditions. Thus, it is likely that
a majority of the known S. Typhimurium fimbrial operons are expressed inside a
mammalian host.
In the current study, we demonstrated that sti, saf, stc, and agf fimbrial genes are
actively expressed in the mouse spleen (Table 1). In vivo expression of these genes is
consistent with a previous study in which CBA mice inoculated with S. Typhimurium
developed antibodies against recombinant His-tagged StiA, StcA, and AgfA (6). The
mice were not evaluated for antibody responses against Saf fimbrial components. In
another study, mice were protected from challenge with S. Typhimurium after injection
with a mixture of purified recombinant His-tagged SafB, a putative chaperone, and
recombinant SafD, the Saf adhesin, both produced in E. coli (29, 30). In addition,
transcription of saf fimbrial genes has been detected in blood samples from patients
infected with S. Typhi (31) and S. Paratyphi A (32), supporting a role for these fimbriae
in the human host.
SafA monomeric fimbriae were assembled in vitro in the presence of the chaperone
protein SafB and crystallized (33). Subsequent crystallographic analysis showed that Saf
TABLE 5 Protective efficacy of RASV strains expressing fimbriae in a constitutive manner
(Saf, Sti, Stc, and Agf) and producing PspA antigena
Strain
Constitutively
expressed
fimbrial gene
No. of mice alive/total no. (% survival)
Expt 1 Expt 2 Combinedb
11595(pYA4088) sti 4/8 (50)c 2/11 (18.2) 6/19 (31.6)c
11850(pYA4088) saf 5/8 (62.5)d 5/11 (45.5) 10/19 (52.6)e
11851(pYA4088) stc 5/8 (62.5)d 5/11 (45.5) 10/19 (52.6)d
12038(pYA4088) agf 3/8 (37.5) 2/11 (18.2) 5/19 (26.3)
11606(pYA4088) (Δ4) 1/8 (12.5) 1/11 (9.1) 2/19 (10.5)
9088(pYA4088) NTf 3/11 (27.3) 3/11 (27.3)
None (PBS) (control) 0/8 (0) 0/11 (0) 0/18 (0)
aSeven-week-old BALB/c mice were immunized orally with ~1  108 CFU of the indicated of S. Typhimurium
vaccine strains and boosted with the same dose 6 weeks later. All mice were challenged by intraperitoneal
inoculation 4 weeks after the booster dose with ~1  104 CFU of virulent S. pneumoniae strain WU2. Deaths
were recorded until 3 weeks postinfection.
bCombined percent survival from two independent experiments.
cSignificantly different (P  0.05) from value obtained for the control (PBS) group.
dSignificantly different (P  0.01) from value obtained for the control (PBS) group.
eSignificantly different (P  0.001) rom value obtained for the control (PBS) group.
fNT, not tested.
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fimbriae are composed of highly flexible fibers formed by globular subunits organized
in a “beads on a string” arrangement (33). Characterization of the safABCD operon
protein sequences suggest that SafA is the major structural protein, SafB is the
periplasmic chaperone, and SafC is an outer membrane usher (29). The SafD protein is
homologous to several other fimbrial adhesins and so is likely to be the Saf adhesin,
believed to be present only at the tip of the fiber (29, 33). In addition, the major fimbrial
protein, SafA, exhibits similarity to the  phage-encoded Bor protein that has been
implicated in serum resistance of -infected hosts (34). Thus, it is possible that the saf
fimbriae play a role in serum resistance.
Our results with agf seem to run counter to a previous report. Using a biolumines-
cence imaging technique, White et al. showed that agfB was not expressed during
infection (35). The authors concluded that Agf fimbriae are not produced in vivo.
However, their observations were based on results obtained from a single time point,
while in our study, the bacteria were under constant selective pressure for 3 days. Thus,
it is possible that there is a temporal component to agfB expression. Our data
suggesting the in vivo production of Agf is also supported by the study we cite above
in which anti-AgfA antibodies were detected in S. Typhimurium-infected mice (6).
In a previous study, strains with either agfAB or stcABCD deleted exhibited wild-type
levels of spleen colonization in genetically resistant CBA mice (16). Consistent with
those results, we observed that strains in which any single fimbrial operon (agf, saf, stc,
or sti) or combination of three operons was deleted had no effect on virulence, while
deletion of all four fimbrial operons resulted in a complete loss of virulence when
mutant strains were administered by the oral route to genetically sensitive BALB/c mice
(Table 2). Our results suggest that these four fimbriae serve functionally redundant roles
in mouse virulence. Interestingly, while a ΔstcABCD strain exhibits wild-type spleen
colonization, it exhibits reduced fecal shedding, indicating a role for this fimbriae in
long-term intestinal carriage (16).
Strain 11484 with sti, saf, stc, and agf deleted was immunogenic, protecting mice
from a high-dose challenge with wild-type S. Typhimurium after a single immunizing
dose as low as 1.4  105 CFU (Table 3). We expanded our analysis of the roles of these
genes in immunogenicity by examining the effect of constitutive production of each
fimbriae individually in a previously characterized vaccine strain background (9088) in
which we had also deleted the other three fimbrial operons. These vaccine strains were
used to deliver the heterologous antigen, PspA. Our results indicate that constitutive
production of Sti, Saf, or Stc, but not Agf, significantly enhanced protective immunity
(Table 5), although they each had different impacts on the immune system.
Th1-type dominant immune responses are frequently observed after immunization
with attenuated Salmonella (36), and most of the fimbrial deletion strains elicited a
Th1-biased response. However, mice immunized with strain 12038(pYA4088) (Agf)
produced more of a mixed Th1/Th2 humoral response, indicating that overproduction
of Agf fimbriae resulted in a reduced ability to stimulate Th1 helper cells to direct IgG
class switching to IgG2a (37). IgG2a is the isotype with the greatest capacity to mediate
complement deposition onto the surfaces of bacteria, and an increase in anti-PspA
IgG2a has been correlated with increased C3 deposition on the S. pneumoniae cell
surface (38).
The immune responses to PspA were examined by measuring the levels of IgG
isotype subclasses. The anti-PspA IgG2a titers were higher than the IgG1 titers in all
groups, indicating that all of the Salmonella vaccines induced a Th1-biased response
against PspA (Fig. 3). Strain 11850(pYA4088) (Saf) elicited high levels of anti-PspA IgG
with a strong Th1 bias (Fig. 3). Thus, the strong Th1 responses observed in mice
vaccinated with strain 11850(pYA4088) (Saf) can explain why this strain was highly
protective (Fig. 3 and Table 3). Strain 11595(pYA4088) (Sti) produced a strong Th1
response by week 9 (Fig. 3A). In contrast, the strains that provided the weakest
protection, 11606(pYA4088) (Δ4) and 12038(pYA4088) (Agf), were deficient in
either strong Th1-biased antibody responses.
The strong protection observed for mice immunized with strain 11851(pYA4088)
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(Stc) does not fit as neatly into this interpretation, as this strain did not elicit a strong
Th1 response at early time points (Fig. 3). However, by week 9, this strain elicited the
greatest IgG2a/IgG1 ratio (Fig. 3C), which may have provided a humoral response that
was adequate to control the S. pneumoniae challenge. This result, along with the results
for strain 12038(pYA4088) (Agf), which stimulated a low IgG2a/IgG1 ratio, indicates
that production of IgG2a is the most important parameter for protection against
pneumococcal challenge in this model.
Deletion of all four fimbrial operons in strain 11484 resulted in complete attenu-
ation (Table 2), while preserving its ability to elicit a protective response against
challenge with wild-type S. Typhimurium at immunizing doses as low as 8.4  102 CFU
(Table 3). In contrast, deletion of these same four fimbrial operons in the 9088
background vectoring PspA compromised the ability of the strain to elicit protection
against streptococcal challenge (Table 5). Since the Δ4 deletion is attenuating, com-
bining these mutations with additional attenuating mutations could have resulted in
overattenuation of the Salmonella vector strain, possibly due to a reduction in the
ability of strain 11606(pYA4088) to colonize the spleen or other lymphoid organs.
While the basis of this overattenuation is not clear, it does indicate that one must
carefully consider the background genotype before combining Δ4 with other attenu-
ating mutations.
This study demonstrates that in vivo-induced fimbriae play a role in spleen coloni-
zation and may be used to augment the immunogenicity of orally administered, live
attenuated Salmonella vaccines. This represents a novel strategy for modulating host
immune responses to strengthen Th1-biased immune responses and enhance protec-
tive immunity.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. Bacterial strains and plasmids used in this
study are listed in Table 4 and Table S1 in the supplemental material. Escherichia coli and Salmonella
enterica serovar Typhimurium strains were routinely cultured at 37°C in LB broth (39) or on LB agar.
Cultures of S. Typhimurium strain 9088 (22) and its derivatives were supplemented with 0.05% mannose
(for Δpmi-2426) and 0.2% arabinose (for ΔPfur33::TT araC PBAD fur). Diaminopimelic acid (DAP) (50 g/ml)
was added to LB medium for growing Δasd mutant strains. The following antibiotics were used as
needed at the indicated concentrations: ampicillin, 100 g/ml; chloramphenicol, 15 g/ml; gentamicin,
20 g/ml; kanamycin, 50 g/ml; tetracycline, 10 g/ml. Carbohydrate-free nutrient broth (NB) was used
for growth when determining lipopolysaccharide (LPS) profiles. LB agar without sodium chloride and
with 7.5% sucrose was employed for sacB-based counterselection. MacConkey agar plates with 1%
mannose were used to indicate sugar fermentation.
For animal experiments, S. Typhimurium strains were grown in LB broth with appropriate supple-
ments. Overnight cultures were diluted 1:100 and grown with shaking (200 rpm) to an optical density at
600 nm of ~0.8. Then, bacteria were centrifuged at 5,000  g for 15 min at room temperature and
resuspended in phosphate-buffered saline (PBS) or buffered saline with 0.01% gelatin (BSG) (40). LB or
Salmonella Shigella (SS) agar plates were used to enumerate S. Typhimurium recovered from tissues.
Selenite cystine broth was employed to enrich samples for S. Typhimurium. Streptococcus pneumoniae
WU2 was cultured on brain heart infusion agar containing 5% sheep blood or in Todd-Hewitt broth with
0.5% yeast extract (41). All media, antibiotics, and chemicals were purchased from BD Difco (Franklin
Lakes, NJ) or Sigma-Aldrich (St. Louis, MO).
General DNA procedures. DNA manipulations, including plasmid and genomic DNA isolation,
restriction enzyme digestions, ligations, and other DNA-modifying reactions, were conducted as de-
scribed previously (42) or were performed according to the manufacturers’ instructions (New England
Biolabs, Ipswich, MA; Qiagen, Valencia, CA; Promega, Madison, WI). Synthesis of primers (Table S2) and
DNA sequencing were performed by Integrated DNA Technologies (Coralville, IA) and the DNA Labora-
tory at Arizona State University (Tempe, AZ), respectively. PCRs were conducted with Klentaq LA
polymerase (DNA Polymerase Technology, St. Louis, MO), possessing proofreading activity. Recombinant
plasmids were introduced into E. coli and S. Typhimurium cells by transformation and electroporation,
respectively.
Construction of transcriptional aph-lacZ fusions. DNA fragments containing the promoter regions
of 12 fimbrial operons were amplified from the S. Typhimurium 3761 genome by PCR using the
appropriate primers (Table S2). The PCR products were digested with ApaI and BamHI and cloned into
the unique ApaI/BamHI sites of aph-lacZ fusion suicide vector pSG3 (43). The resulting plasmids were
introduced by conjugation into S. Typhimurium strain 3761 to obtain fusions of selected promoter
regions with aph-lacZ genes by a single-crossover event as previously described (43).
In vivo expression technology (IVET). Each S. Typhimurium aph-lacZ fusion strain was grown
statically in LB broth at 37°C for 20 h. Bacterial cells were harvested by centrifugation at 5,000  g for
15 min at room temperature. The pellets were resuspended in BSG buffer. BALB/c mice were inoculated
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orally with ~1  109 CFU of the mixture of the 12 aph-lacZ fusion strains. Mice were treated with
kanamycin at 3, 24, and 48 h postinoculation by oral administration (2 mg in 20 l) and intraperitoneal
(10 mg in 100 l) injection. Three days after inoculation, the spleens were collected from the treated mice
and homogenized. Dilutions of the homogenate were made in BSG and plated onto LB agar plates
supplemented with gentamicin and incubated overnight at 37°C. Finally, selected clones were identified
by PCR using specific primers (Table S2).
Construction of suicide plasmids for introduction of deletions or Pfimbrial operon::PmurA dele-
tion/insertions of fimbrial operons. To construct the ΔstiABCH1225, ΔsafABCD31, and ΔstcABCD36
deletions, two-step PCR mutagenesis was used. First, two DNA fragments flanking fimbrial operons were
amplified from the S. Typhimurium 3761 genome using appropriate primer sets: PstiF/PstiR (P stands for
primer, F stands for forward, and R stands for reverse) and d-stiAH-F/d-stiAH-R (d stands for deletion) (for
ΔstiABCH1225), PsafF/PsafR and d-safAD-F/d-safAD-R (for ΔsafABCD31), and PstcF/PstcR and d-stcAD-F/
d-stiAD-R (for ΔstiABCH1225) (Table S2). Thereafter, the mixes of two PCR products flanking each fimbrial
operon were used as the templates in the next amplification reactions with PstiF/d-stiAH-R, PsafF/d-
safAD-R, and PstcF/d-stcAD-R primers, respectively. The DNA fragments obtained were digested with
ApaI/SacI restriction enzymes and cloned into suicide plasmid vector pCHSUI-1. The resulting plasmids,
pYA4584, pYA4586, and pYA5007, carried deletions of the entire stiABCH, safABCD, and stcABCD operons,
respectively. Plasmids pYA3490 and pYA4941 for introduction of the agfD812 and Δ(agfC-agfG)-999
mutations were described previously (24, 44).
To construct the ΔPstiA52::PmurA stiA52, ΔPstcA53::PmurA stcA53, and ΔPsafA55::PmurA safA55 deletion/
insertion mutations, two-step PCR mutagenesis was also used. DNA fragments containing the upstream
regions of the stiA, stcA, and safA promoters were amplified from the S. Typhimurium 3761 genome
using PmurA-stiA-F/PmurA-stiA-R, PmurA-stcA-F/PmurA-stcA-R, and PmurA-safA-F/PmurA-safA-R primer
pairs (Table S2), respectively. The PCR products were digested with BglII. A 65-bp murA promoter region
was amplified from E. coli K-12 using primers Ec_PmurA-F and Ec_PmurA-R (Ec stands for E. coli). This PCR
product was digested with BglII and NcoI. DNA fragments containing downstream regions of the stiA,
stcA, and safA promoters were amplified from the S. Typhimurium 3761 genome using PmurA-stiA-F1/
PmurA-stiA-R1, PmurA-stcA-F1/PmurA-stcA-R1, and PmurA-safA-F1/PmurA-safA-R1 primer pairs, respec-
tively. The PCR products were digested with NcoI. Two digested PCR products containing flanking
regions of each fimbrial operon and a PCR product containing the murA promoter were combined by
ligation and used as the templates for PCR to amplify the combined DNA fragments using PmurA-stiA-
F/PmurA-stiA-R, PmurA-stcA-F/PmurA-stcA-R1, and PmurA-safA-F/PmurA-safA-R1 primer pairs, respec-
tively. These final PCR products were digested with KpnI and SacI and cloned into the unique KpnI/SacI
sites of suicide vector pRE112 to generate pYA5052, pYA5053, and pYA5054.
Construction of S. Typhimurium mutants. All S. Typhimurium mutants were derived from the
highly virulent parent strain 3761 (45). The genealogy of constructed strains is shown in Table S1. All
gene replacements were introduced by conjugational transfer of suicide plasmids using donor E. coli
strain 7213 (46). All mutations were verified by PCR. We confirmed arabinose-regulated Fur production
by Western blotting. The Δpmi mutation was confirmed by white colony phenotype on mannose-
MacConkey agar. Lipopolysaccharide (LPS) profiles were examined by silver staining of 12% polyacryl-
amide gels as described previously (47).
SDS-PAGE and Western blotting. SDS-PAGE and Western blotting were performed by standard
techniques. The blots were developed with nitroblue tetrazolium chloride/5-bromo-4-chloro-3=-indolyl
phosphate (Amresco, Solon, OH) or Pierce ECL Western blotting substrate (Thermo Scientific), using
rabbit polyclonal anti-rPspA serum as primary antibodies and mouse anti-rabbit IgG alkaline phosphatase
conjugate (Sigma-Aldrich) as secondary antibodies.
Animal supply and housing. Female BALB/c mice (6 to 8 weeks old) were obtained from Charles
River Laboratories (Wilmington, MA). Animals were allowed to acclimate for 1 week after arrival before
starting the experiments. All animal procedures were carried out in compliance with the Institutional
Animal Care and Use Committee (IACUC) at Arizona State University and the Animal Welfare Act.
Colonization of the mouse spleen and determination of the competitive index. BALB/c mice
were inoculated intraperitoneally with a mixture containing ~1  104 of S. Typhimurium wild-type strain
(3761) and either strain 11484 or strain 11599 suspended in 100 l of PBS. Wild-type and mutant
strains were marked with low-copy-number chloramphenicol- or kanamycin-resistant plasmids: pHSG576
and pWSK129, respectively. On days 1 and 3 postinoculation, three mice in each group were euthanized,
and the spleens and livers were collected to determine the colonization levels. The competitive index (CI)
for each strain compared to the wild type was calculated by dividing the ratio of two strains from an
organ divided by the same ratio in the suspension used for the infection.
Determination of the 50% lethal dose. Freshly grown bacterial cultures were pelleted by centrif-
ugation at 5,000  g for 15 min at room temperature. Bacterial pellets were resuspended in BSG and
adjusted to achieve a dose of ~102 to ~109 CFU in a volume of 20 l for orally inoculating BALB/c mice.
Animals were observed for typhoid symptoms for 3 weeks postinoculation. Deaths were recorded daily.
The 50% lethal dose (LD50) was calculated using the Reed and Muench method (48).
Immunization and pneumococcal challenge. BALB/c mice were inoculated orally with 20 l of PBS
containing ~1 108 CFU of the appropriate S. Typhimurium strain and boosted with the same strain and
dose 6 weeks later. No food or water was provided for ~4 h prior to immunizations. Groups of mice
inoculated with PBS served as a control. At week 10 (i.e., 4 weeks after the booster), all mice were
challenged by intraperitoneal injection with ~1  104 CFU of S. pneumoniae WU2 in 100 l of BSG
(equivalent to 40 times the LD50). Mice were monitored daily for 3 weeks.
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Antigen preparation and ELISA. Recombinant PspA (rPspA) protein was purified from E. coli
BL21(DE3)(pYA4085) as described previously (49). Antibody titers in serum and vaginal washes were
determined by enzyme-linked immunosorbent assay (ELISA) as described previously (50).
Statistical analyses. All statistical analyses were performed using GraphPad Prism 6 (GraphPad
Software, San Diego, CA). The significance of the different values obtained was appraised using two-way
analysis of variance (ANOVA) followed by Dunnett’s tests (for ELISA). For challenge experiments, log rank
(Mantel-Cox) test was used to determine the significant differences between the survival curves. For CI
assays, the geometric means of the CIs were determined, and a Student’s t test was used to determine
whether the logarithmically transformed ratios differed significantly from zero. P values of 0.05 were
considered significant.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.01189-17.
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